Clinical trial
Multicenter Randomized Controlled Clinical Trial of Indocyanine Green Molecular Fluorescence Imaging in the Diagnosis and Treatment of Primary Liver Cancer
NCT05160740 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Randomized Controlled Clinical Trial of Indocyanine Green Molecular Fluorescence Imaging in the Diagnosis and Treatment of Primary Liver Cancer
- Lead sponsor
- Zhujiang Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 23, 2021
- Completion date
- December 31, 2025
- Enrollment
- 348 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver cancer